Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV's pipeline of antimalarial drugs
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Antimalarial drug availability
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Antimalarial drug toolkits
Artesunate injection dosage & administration
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Intellectual property rights (IPR)
Clinical centre partners by country
Our impact
Milestones
Malaria stories from the field
Antimalarial drugs for children
Gender equity
Global health security
Antimicrobial resistance to antimalarials
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
5 species of
Plasmodium
parasites
Lifecycle of malaria parasite
Malaria facts & statistics
Malaria treatment
History of antimalarial drugs
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
The Global Health Priority Box
About the Global Health Priority Box
Supporting information
Request the Global Health Priority Box
Terms & conditions
Malaria
Libre
Malaria
Libre
open innovation platform
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News
News
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
21 found
WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester
28 Nov 2022
This World Malaria Day MMV joins Swiss Malaria Group in calling for increased commitment to combatting malaria
22 Apr 2022
First-ever malaria vaccine to get WHO recommendation for roll-out
07 Oct 2021
MMV recognizes partner Novartis’ milestone of 1 billion courses of antimalarial delivered
18 May 2021
MMV presents Lifetime Achievement Awards to three longstanding collaborators
25 Nov 2019
Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO
19 Nov 2018
MMV Project of the Year 2017 awarded to Sanofi
10 Jul 2018
MMV brings new partner Janssen Pharmaceuticals on board
19 Jan 2017
European regulators grant Pyramax® a revised label
20 Nov 2015
MMV joins the Asia Pacific Malaria Elimination Network (APMEN)
23 Apr 2015
Call for stories and ideas for GMAP2
20 Nov 2014
MMV and Merck Serono join forces in antimalarial drug discovery
24 Feb 2014
Takeda collaborates with MMV through GHIT Fund
24 Dec 2013
World Malaria Report 2011 highlights fragile progress
13 Dec 2011
MMV ESAC member receives accolade for malaria research
22 Aug 2011
Pyramax® edges closer to patients
19 Aug 2011
DHODH awarded MMV’s Project of the Year 2010
01 Jun 2011
MMV signs MoU with ALMA at the African Union Summit
03 Feb 2011
Roll Back Malaria (RBM) Partnership Call for Nomination for Research and Academia constituency
08 Apr 2010
Outstanding review of MMV by Philanthropy Advisory Service
01 Dec 2009
The power of partnership
16 Apr 2009